Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02121990
Title Dose-Escalation Study of Intraperitoneal (IP) Cisplatin, IV/IP Paclitaxel, IV Bevacizumab, and Oral Olaparib for Newly Diagnosed Ovarian, Primary Peritoneal, and Fallopian Tube Cancer
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan-Kettering Cancer Center
Indications

fallopian tube carcinoma

peritoneal carcinoma

ovarian carcinoma

Therapies

Bevacizumab + Cisplatin + Olaparib + Paclitaxel

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Memorial Sloan Kettering Cancer Center at Basking Ridge Basking Ridge New Jersey 07920 United States Details
Memorial Sloan Kettering Cancer Center @ Suffolk Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering Cancer Center at Mercy Medical Center Rockville Centre New York 11570 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field